Rasch analysis of the hospital anxiety and depression scale in Parkinson's disease

The hospital anxiety and depression scale (HADS) is commonly used to assess mood in Parkinson's disease (PD) patients. Very few studies analyze the scale from the standpoint of item response theory. This article sought to analyze how the HADS fits the Rasch model in PD. The HADS was administered to 387 PD patients. Three sets of Rasch analyses were performed for the HADS total score, and anxiety and depression subscales (HADS‐T, ‐A, and ‐D, respectively). Although the HADS‐T and HADS‐A displayed a good fit, with little threshold disordering and no differential item functioning, the HADS‐D failed to fit the model. The person separation index, a reliability measure, was 0.87 (HADS‐T) and 0.80 (HADS‐A). Both HADS‐T and HADS‐A showed unidimensionality. Our results supported the use of HADS‐T as a measure of psychological distress in PD patients. Moreover, the HADS‐A was also an adequate anxiety measure. Further research is required to address the use of HADS‐D in PD. © 2008 Movement Disorder Society

[1]  W. Tang,et al.  Examining item bias in the anxiety subscale of the Hospital Anxiety and Depression Scale in patients with chronic obstructive pulmonary disease , 2008, International journal of methods in psychiatric research.

[2]  P. Selby,et al.  Rasch analysis of the dimensional structure of the Hospital Anxiety and Depression Scale , 2006, Psycho-oncology.

[3]  I. Arostegui,et al.  Evaluation of the psychometric characteristics of the Spanish version of the Hospital Anxiety and Depression Scale , 2003, Acta psychiatrica Scandinavica.

[4]  A. Bulbena,et al.  A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population. , 2003, General hospital psychiatry.

[5]  P. Martínez-Martín,et al.  Two questionnaires for Parkinson’s disease: are the PDQ-39 and PDQL equivalent? , 2007, Quality of Life Research.

[6]  Colin R. Martin,et al.  A psychometric evaluation of the Hospital Anxiety and Depression Scale in patients diagnosed with end-stage renal disease. , 2004, The British journal of clinical psychology.

[7]  P. Martínez-Martín,et al.  Anxiety and depression: main determinants of health-related quality of life in Brazilian patients with Parkinson's disease. , 2008, Parkinsonism & related disorders.

[8]  D. Razavi,et al.  Screening for Adjustment Disorders and Major Depressive Disorders in Cancer In-Patients , 1990, British Journal of Psychiatry.

[9]  Georg Rasch,et al.  Probabilistic Models for Some Intelligence and Attainment Tests , 1981, The SAGE Encyclopedia of Research Design.

[10]  William W. McDonald,et al.  Depression rating scales in Parkinson's disease: Critique and recommendations , 2007, Movement disorders : official journal of the Movement Disorder Society.

[11]  P. Martínez-Martín,et al.  Validation and cross-cultural adjustment of PDQL-questionnaire, Spanish version (Ecuador) (PDQL-EV). , 2004, Parkinsonism & related disorders.

[12]  Alan Tennant,et al.  The Rasch measurement model in rheumatology: what is it and why use it? When should it be applied, and what should one look for in a Rasch paper? , 2007, Arthritis and rheumatism.

[13]  W. Gibb,et al.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[14]  A. Stiggelbout,et al.  Evaluation of the Hospital Anxiety and Depression Scale in Patients With Parkinson's Disease , 2002, Clinical neuropharmacology.

[15]  Marjan Jahanshahi,et al.  The Validity of the Hospital Anxiety and Depression Scale and the Geriatric Depression Scale in Parkinson’s Disease , 2006, Behavioural neurology.

[16]  Julie F Pallant,et al.  An introduction to the Rasch measurement model: an example using the Hospital Anxiety and Depression Scale (HADS). , 2007, The British journal of clinical psychology.

[17]  C. Herrmann.  International experiences with the Hospital Anxiety and Depression Scale--a review of validation data and clinical results. , 1997, Journal of psychosomatic research.

[18]  G. Huston.  The Hospital Anxiety and Depression Scale. , 1987, The Journal of rheumatology.

[19]  Cristina Pecci.  [Chronic disease and quality of life]. , 2007, Vertex.

[20]  Everett V. Smith.  Detecting and evaluating the impact of multidimensionality using item fit statistics and principal component analysis of residuals. , 2002, Journal of applied measurement.

[21]  P. Martínez-Martín,et al.  Determinants of quality of life in Brazilian patients with Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[22]  Grupo Elep.  Estudio longitudinal de pacientes con enfermedad de Parkinson (ELEP) : objetivos y metodología , 2006 .

[23]  M. Jahanshahi,et al.  Evaluation of anxiety in Parkinson’s disease with some commonly used rating scales , 2007, Neurological Sciences.

[24]  M. Sordo,et al.  Caregiver burden in Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[25]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[26]  I. Nagyova,et al.  Clinical and psychosocial factors associated with fatigue in patients with Parkinson's disease. , 2008, Parkinsonism & related disorders.

[27]  W. Tang,et al.  Rasch analysis of the scoring scheme of the HADS Depression subscale in Chinese stroke patients , 2007, Psychiatry Research.

[28]  T. T. Haug,et al.  The validity of the Hospital Anxiety and Depression Scale. An updated literature review. , 2002, Journal of psychosomatic research.

[29]  A. Tennant,et al.  The Behçet's disease activity index. , 2003, Advances in experimental medicine and biology.